黑料网

ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 2091

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Share This Page

Effect of ingested fluticasone propionate on Eosinophilic esophagitis

4th International Conference on Gastroenterology

Ahmed Ellakany, H AbouElKhier and M Bedawey

ScientificTracks Abstracts: J Gastrointest Dig Syst

DOI:

Abstract
Eosinophilic esophagitis is a clinicopathologic disease characterized by upper intestinal symptoms and the finding of more than 15 or 20 eosinophils in the esophageal epithelium. Lack of awareness to EoE among some gastroenterologists made the disease under recognized. Patients with eosinophilic esophagitis should be referred to both an allergist and gastroenterologist for optimal management which may include dietary modifications, pharmacologic agents, ingested fluticasone and its role in EOE will be discussed in this study. This study was conducted at faculty of medicine,Alexandria University, Internal Medicine Department. The study was conducted on twenty patients who were complaining from recurrent dysphagia and done upper GIT endoscopyand diagnosed histopathologically as EOE. The 20 patients was randomly assigned to receive either placebo (n=10) or swallowed fluticasone (n=10). Treatment lasted for four weeks and follow up extended up to 8 months. After 4 weeks treatment, clinical symptoms and histological changes were evaluated. Histologic improvement in the form of full histological remission was seen in seven patients in the fluticasone group compared with one patient who achieved remission in the placebo group. In conclusion, the study highlights the problems of diagnosis and lack of awareness and understanding of the etiology and pathogenesis of the disease. The use of ingested fluticasone showed improvement of symptoms and histological pattern.
Biography
International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top